University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhancer reprogramming, occurs ...
Sep 29, 2023
0
66
The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.
Sep 5, 2013
0
0
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new ...
Mar 1, 2021
0
89
(Medical Xpress)—Scientists at the University of Kansas are working toward a potential breakthrough therapy for a host of autoimmune diseases. Long a goal of immunology, the approach targets only the handful of dangerous ...
May 9, 2014
0
0
Obesity has been previously linked to an increased risk of cancer, but most studies have not differentiated the risks between male and female patients. A new study published June 12 in the journal Cancer Cell takes a closer ...
Jun 12, 2023
0
87
For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer.
Mar 16, 2023
0
4
Mutating cells can prevent the spread of cancer by flipping themselves into a state of reduced activity called senescence. Cancer genes, however, can retaliate by reviving those cells so they can replicate again.
Apr 21, 2023
0
25
An interdisciplinary team of researchers at the Otto-von-Guericke University in Magdeburg has gained new insights into how inflammatory mediators of pathogen defense can remotely drive cancer cells into death—an important ...
Jun 23, 2023
0
130
In Norway, more than 3,300 people contract lung cancer every year. It is the second most common form of cancer among both women and men, after breast and prostate cancer, respectively. It also exhibits the highest cancer ...
Jun 30, 2022
0
10
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.
Dec 12, 2018
0
23
